{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:15:11Z","timestamp":1744344911217,"version":"3.40.4"},"reference-count":10,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"DOI":"10.1182\/blood.2024027994","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:32:23Z","timestamp":1744299143000},"page":"1596-1597","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["SMAC mimetics in action in chronic myeloid leukemia"],"prefix":"10.1182","volume":"145","author":[{"given":"Ali G.","family":"Turhan","sequence":"first","affiliation":[{"name":"University Paris Saclay 1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"15","key":"2025041015321711900_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2024025286","article-title":"High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.","volume":"145","author":"Nygr\u00e9n","year":"2025","journal-title":"Blood"},{"issue":"11","key":"2025041015321711900_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/ajh.27443","article-title":"Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"99","author":"Jabbour","year":"2024","journal-title":"Am J Hematol"},{"issue":"24","key":"2025041015321711900_bib3","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2025041015321711900_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in\u00a0vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"issue":"13","key":"2025041015321711900_bib5","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Chomel","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2025041015321711900_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2016.68.2914","article-title":"Long-term follow-up of the French Stop Imatinib (STIM1) study in patients with chronic myeloid leukemia","volume":"35","author":"Etienne","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2025041015321711900_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/leu.2016.360","article-title":"Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia","volume":"31","author":"Ilander","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"2025041015321711900_bib8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood.V99.6.2107","article-title":"Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression","volume":"99","author":"Baron","year":"2002","journal-title":"Blood"},{"issue":"1","key":"2025041015321711900_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"issue":"11","key":"2025041015321711900_bib10","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1158\/1535-7163.MCT-15-0475","article-title":"A\u00a0phase I study of the SMAC-mimetic birinapant in adults with refractory solid tumors or lymphoma","volume":"14","author":"Amaravadi","year":"2015","journal-title":"Mol Cancer Ther"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/15\/1596\/2367928\/blood_bld-2024-027994-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/145\/15\/1596\/2367928\/blood_bld-2024-027994-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:32:25Z","timestamp":1744299145000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/145\/15\/1596\/536487\/SMAC-mimetics-in-action-in-chronic-myeloid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":10,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,4,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027994","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}